Table 2 Small molecules facilitating somatic cell reprogramming and their function
From: Generation of pluripotent stem cells without the use of genetic material
Small molecules | C a | Host animal | Function | TFs to be replaced or function | Reference |
---|---|---|---|---|---|
5-aza-CR, AZA | 0.5 mM | Mouse | DMNT inhibitor | Promotion of reprogrammming | |
RG108 | 0.04–500 μM | Mouse | DMNT inhibitor | Sox2 (with BIX) or Oct4 | |
RSC133 | 10 μM | Human | DMNT inhibitor, Histone deacetylase inhibitor | Promotion of reprogramming | |
Sodium butyrate | 0.5–1 mM | Mouse, human | HDAC inhibitor | Promotion of reprogramming | |
SAHA | 5 μM | Mouse | HDAC inhibitor | Promotion of reprogramming | |
TSA | 20 nM | Mouse | HDAC inhibitor | Promotion of reprogramming | |
VPA | 0.5–2 mM | Mouse, human | HDAC inhibitor | Promotion of reprogramming | |
Tranylcypromine (Parnate) | 5–10 μM | Mouse | H3K4 demethylation inhibitor (epigenetic modulator) | Promotion of reprogramming | |
BIX | 0.5–2 μM | Mouse | G9a HMTase inhibitor | Oct4 | |
CHIR | 3–10 μM | Mouse, human | GSK-3β inhibitor that activate Wnt signalling pathway | Sox2 | |
Kenpaullone | 5 μM | Mouse | GSK-3/CDKs inhibitor | Klf4 | |
Compound B6 | 1 μM | Mouse | AKt-mediated inhibitor of GSK3-β | Promotion of reprogramming | |
LiCl | 5–10 mM | Mouse and human | GSK-3β inhibitor, LSD1 inhibitor | Promotion of reprogramming | |
616452 (E-616452, RepSox) | 1 μM | Mouse, human | TGF-β inhibitor (ALKinhibitor II) | Sox2 | |
A83-01 | 0.5 μM | Mouse, human | TGF-β inhibitor | Promotion of reprogramming | |
LY-364947 | 1 μM | Mouse | TGF-β inhibitor | Sox2 | |
SB431542 | 2 μM | Mouse, human | TGF-β inhibitor | Promotion of reprogramming | |
PD0325901 (PD) | 0.5–1 μM | Mouse, human | MEK inhibitor | Promotion of reprogramming | |
AMI-5 | 5 μM | Mouse | Protein arginine methyltransferase inhibitor | Sox2, Klf4 (with A-83-01) | |
N-oxaloylglycine | 1 μM | Human | Prolyl-4-hydroxylase inhibitor | Promotion of reprogramming | |
Compound B4 (TGFb-RI ) | 1 μM | Mouse | ALK4 inhibitor | Promotion of reprogramming | |
Dasatinib | 0.5 μM | Mouse | Src family tyrosine kinase inhibitor | Sox2 | |
iPY razine (iPY) | 10 μM | Mouse | Src family tyrosine kinase inhibitor | Sox2 | |
PP1 | 10 μM | Mouse | Src family tyrosine kinase inhibitor | Sox2 | |
Rapamycin | 0.3 nM | Mouse | mTOR inhibitor | Promotion of reprogramming | |
Compound B8 | 1–2 μM | Mouse | IP3K inhibitor | Promotion of reprogramming | |
Compound B10 | 1–2 μM | Mouse | P38 kinase inhibitor | Promotion of reprogramming | |
D4476 | 5 μM | Mouse | CK1 inhibitor | Oct 4 with FSK and 2-Me-5HT | |
BayK | 2 μM | Mouse | a L-channel calcium agonist | Sox2 | |
FSK | 10–50 μM | Mouse | cAMP agonist | Oct4 with 2-Me-5HT), and D4476 | |
Prostaglandin E2 | 5 μM | Mouse | cAMP agonist | Promotion of reprogramming | |
Rolipram | 10 μM | Mouse | cAMP agonist | Promotion of reprogramming | |
2-Me-5HT | 5 μM | Mouse | 5-HT3 agonist | Oct4 with FSK and D4476 | |
5-(4-Chloro-phenyl)-3-phenyl-pent-2-enoic acid (PS48) | 5 μM | human | PDK1 activator | Promotion of reprogramming | |
8-Br-cAMP | 0.1–0.5 mM | Human | cAMP-dependent protein kinase activator | Promotion of reprogramming | |
Fructose 2,6-bisphosphate | 10 mM | Human | Phosphofructokinase 1 activator | Promotion of reprogramming | |
Quercetin | 1 μm | Human | Hypoxia-inducible factor pathway activator | Promotion of reprogramming | |
DZNep | 0.05–0.1 μM | Mouse | Epigenetic modulators | Promotion of reprogramming | |
DNP | 1 μM | Human | Oxidative phosphorylation uncoupler | Promotion of reprogramming | |
TTNPB | 1 μM | Mouse | Retinoic acid receptor ligand | Promotion of reprogramming | |
Oxysterol | 0.5–1 μM | Mouse | Sonic hedgehog signaling | Sox2, Klf4, and C-Myc | |
Purmorphamine | 0.5–1 μM | Mouse | Sonic hedgehog signaling | Sox2, Klf4, and C-Myc | |
Shh | 500 ng/ml | Mouse | Sonic hedgehog signaling | Sox2, Klf4, and C-Myc |